"Exons" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.
| Descriptor ID |
D005091
|
| MeSH Number(s) |
G05.360.340.024.340.137.232
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Exons".
Below are MeSH descriptors whose meaning is more specific than "Exons".
This graph shows the total number of publications written about "Exons" by people in this website by year, and whether "Exons" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 8 | 9 |
| 1994 | 0 | 6 | 6 |
| 1995 | 3 | 6 | 9 |
| 1996 | 1 | 13 | 14 |
| 1997 | 3 | 10 | 13 |
| 1998 | 1 | 10 | 11 |
| 1999 | 2 | 12 | 14 |
| 2000 | 1 | 17 | 18 |
| 2001 | 2 | 8 | 10 |
| 2002 | 3 | 15 | 18 |
| 2003 | 2 | 16 | 18 |
| 2004 | 2 | 9 | 11 |
| 2005 | 2 | 10 | 12 |
| 2006 | 3 | 5 | 8 |
| 2007 | 0 | 12 | 12 |
| 2008 | 0 | 9 | 9 |
| 2009 | 0 | 13 | 13 |
| 2010 | 3 | 13 | 16 |
| 2011 | 2 | 14 | 16 |
| 2012 | 3 | 11 | 14 |
| 2013 | 1 | 4 | 5 |
| 2014 | 0 | 9 | 9 |
| 2015 | 3 | 7 | 10 |
| 2016 | 4 | 6 | 10 |
| 2017 | 2 | 7 | 9 |
| 2018 | 2 | 4 | 6 |
| 2019 | 3 | 2 | 5 |
| 2020 | 2 | 3 | 5 |
| 2021 | 2 | 3 | 5 |
| 2022 | 0 | 4 | 4 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Exons" by people in Profiles.
-
Exon architecture controls mRNA m6A suppression and gene expression. Science. 2023 02 17; 379(6633):677-682.
-
spKAS-seq reveals R-loop dynamics using low-input materials by detecting single-stranded DNA with strand specificity. Sci Adv. 2022 12 02; 8(48):eabq2166.
-
Profiling lariat intermediates reveals genetic determinants of early and late co-transcriptional splicing. Mol Cell. 2022 12 15; 82(24):4681-4699.e8.
-
The sequences of 150,119 genomes in the UK Biobank. Nature. 2022 07; 607(7920):732-740.
-
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clin Cancer Res. 2022 03 15; 28(6):1117-1126.
-
Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial. J Clin Oncol. 2022 03 01; 40(7):710-718.
-
AUTS2 Regulates RNA Metabolism and Dentate Gyrus Development in Mice. Cereb Cortex. 2021 08 26; 31(10):4808-4824.
-
An APP ectodomain mutation outside of the A? domain promotes A? production in vitro and deposition in vivo. J Exp Med. 2021 06 07; 218(6).
-
A novel familial SCN5A exon 20 deletion is associated with a heterogeneous phenotype. J Electrocardiol. 2021 May-Jun; 66:131-135.
-
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program. Eur J Cancer. 2021 05; 149:235-248.